May 17, 2020

The Biggest Mistakes Doctor’s Make on Social Media and How to Avoid Them

healthcare
Social Media
doctors
Facebook
Admin
2 min
There are certain aspects that should be avoided when utilizing digital platforms.
Social media is a great and powerful tool that, when used correctly, can have a wonderful impact on a society, a business, a career, etc. However, with...

Social media is a great and powerful tool that, when used correctly, can have a wonderful impact on a society, a business, a career, etc. However, with the good, often comes the bad. And though Facebook, Twitter and Instagram can offer various ways to educate patients and engage with them, there are certain aspects that should be avoided when utilizing digital platforms. Take a look:

Don’t Over-promote Yourself

It’s important to remember to promote conversation—not your business or craft. While it’s perfectly fine to endorse your abilities here and there, the main focus of your social media platform should be to provide interesting and beneficial information that will eventually create a dialogue or some sort of feedback with current or potential patients. After all, you don’t want to force yourself onto potential patients, but instead form a relationship with them through trust and understanding.  

RELATED TOPIC: The 3 Social Media Platforms Your Health Care Organization Needs to Be Using

Be Reasonable AND Patient

As you start down your social media path, it’s important to not only be patient, but to also have reasonable expectations and goals. For example, it will take time and energy to build an effective relationship with people. Therefore, don’t expect your business to substantially grow overnight just because of your Facebook, Twitter and Instagram efforts. Not only are you trying to earn people’s trust, but you are doing so via online—be patient.

RELATED TOPIC: 8 Essential Social Media Tools Doctors Should Be Using Right

Always Be Professional

Yes, most people have personal Facebook, Twitter and Instagram accounts. You have to remember that you’re utilizing Facebook, Twitter and Instagram for professional purposes, not personal ones. Therefore, to avoid potential legal situations, you must be able to distinguish between the two. Before you post, be aware of patient confidentially and make sure your ethics are in-check.

Follow us on Twitter (@HealthcareGlbl) and like us on Facebook

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article